UnitedHealth Group's strong Q3 earnings, with revenues growing 12.4% to $56.6 billion and adjusted earnings per share increasing 28% to $3.41, indicate a positive trend for the company. The company's guidance for 2018, with adjusted earnings per share expected to approach $12.80, suggests continued growth. Additionally, the company's diverse portfolio, including its Optum and UnitedHealthcare segments, provides a stable foundation for future growth. Management's tone and outlook for 2019 also suggest confidence in the company's ability to continue delivering strong results.

[2]